In focus · trending topic

EORTC NCI AACR 2016

1 stories · following the connections

Cyclacel’s Novel PLK1 Inhibitor, CYC140, Demonstrates Therapeutic Potential in Esophageal Cancer and Acute Leukemia

By Nasdaq OMXDec 1, 2016, 12:00 PM UTC